QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lin, S. Articles by Shyu, K.-G. Search for Related Content PubMed PubMed Citation Articles by Lin, S. Articles by Shyu, K.-G.

Berberine Inhibits HIF-1 Expression via Enhanced Proteolysis

Departments of Medical Education and Research (S.L., S.-C.T., C.-C.L., B.-W.W., K.-G.S.) and Internal Medicine (J.-Y.L.), Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan, Republic of China; and Graduate Institute of Medical Sciences, Taipei Medical University, Taipei, Taiwan, Republic of China (K.-G.S.)

We have studied the antiangiogenic property of berberine. We showed that berberine could directly inhibit in vitro human umbilical vein endothelial cell (HUVEC) tube formation and migration. In addition, to determine whether berberine could influence the cross-talk between the gastric adenocarcinoma cell line SC-M1 and vascular endothelial cells, we performed modified confrontation culture experiments and showed that berberine (7.5 µM, 16 h) could inhibit the capacity of hypoxic SC-M1 cells to stimulate HUVEC migration. These results demonstrated berberine's antiangiogenic property and its clinical potential as an inhibitor of tumor angiogenesis. Parallel Western blot analyses revealed that berberine prevented hypoxic SC-M1 cultures from expressing vascular endothelial growth factor (VEGF) and hypoxia-inducible factor (HIF)-1, two key factors in mediating tumor angiogenesis. However, overexpression of HIF-1 in SC-M1 cells dramatically reversed the inhibitory effect of berberine on SC-M1–induced in vitro HUVEC migration. These data indicated that HIF-1 repression is a critical step in the inhibitory effect of berberine on tumor-induced angiogenesis. Northern blot analyses plus pulse-chase assays revealed that berberine did not down-regulate HIF-1 mRNA but destabilized HIF-1 protein. We found that berberine-induced HIF-1 degradation was blocked by a 26S proteasome inhibitor. Moreover, immunoprecipitation and Western blot analyses showed that berberine increased the lysine-acetylated HIF-1 in hypoxic SC-M1 cultures. These data indicated that a proteasomal proteolytic pathway and lysine acetylation were involved in berberine-triggered HIF-1 degradation. In conclusion, our data provided molecular evidence to support berberine as a potent antiangiogenic agent in cancer therapy.

Address correspondence to: Kou-Gi Shyu, Address: The Department of Medical Education and Research, Shin Kong Wu Ho-Su Memorial Hospital, 95 Wen Chang Road, Shih Lin, Taipei 111, Taiwan, R.O.C. E-mail: shyukg{at}ms12.hinet.net

This article has been cited by other articles:

				C. V. Pereira, N. G. Machado, and P. J. Oliveira Mechanisms of Berberine (Natural Yellow 18)-Induced Mitochondrial Dysfunction: Interaction with the Adenine Nucleotide Translocator Toxicol. Sci., October 1, 2008; 105(2): 408 - 417. [Abstract] [Full Text] [PDF]

				M. K. Pandey, B. Sung, A. B. Kunnumakkara, G. Sethi, M. M. Chaturvedi, and B. B. Aggarwal Berberine Modifies Cysteine 179 of I{kappa}B{alpha} Kinase, Suppresses Nuclear Factor-{kappa}B-Regulated Antiapoptotic Gene Products, and Potentiates Apoptosis Cancer Res., July 1, 2008; 68(13): 5370 - 5379. [Abstract] [Full Text] [PDF]

				G. C. Pereira, A. F. Branco, J. A. C. Matos, S. L. Pereira, D. Parke, E. L. Perkins, T. L. Serafim, V. A. Sardao, M. S. Santos, A. J. M. Moreno, et al. Mitochondrially Targeted Effects of Berberine [Natural Yellow 18, 5,6-dihydro-9,10-dimethoxybenzo(g)-1,3-benzodioxolo(5,6-a) quinolizinium] on K1735-M2 Mouse Melanoma Cells: Comparison with Direct Effects on Isolated Mitochondrial Fractions J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 636 - 649. [Abstract] [Full Text] [PDF]

				O. Iliopoulos Molecular Biology of Renal Cell Cancer and the Identification of Therapeutic Targets J. Clin. Oncol., December 10, 2006; 24(35): 5593 - 5600. [Abstract] [Full Text] [PDF]

				R. Cairns, I. Papandreou, and N. Denko Overcoming Physiologic Barriers to Cancer Treatment by Molecularly Targeting the Tumor Microenvironment Mol. Cancer Res., February 1, 2006; 4(2): 61 - 70. [Abstract] [Full Text] [PDF]

				R. Bilton, N. Mazure, E. Trottier, M. Hattab, M.-A. Dery, D. E. Richard, J. Pouyssegur, and M. C. Brahimi-Horn Arrest-defective-1 Protein, an Acetyltransferase, Does Not Alter Stability of Hypoxia-inducible Factor (HIF)-1{alpha} and Is Not Induced by Hypoxia or HIF J. Biol. Chem., September 2, 2005; 280(35): 31132 - 31140. [Abstract] [Full Text] [PDF]